This brand name is authorized in Austria, Cyprus, Finland, France, Poland, South Africa
The drug PEVISONE contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Econazole
UNII H438WYN10E - ECONAZOLE NITRATE
|
|
Econazole nitrate is a broad spectrum antimycotic with activity against dermatophytes, yeasts and moulds. A clinically relevant action against Gram positive bacteria has also been found. |
|
2
Triamcinolone
UNII F446C597KA - TRIAMCINOLONE ACETONIDE
|
|
Triamcinolone acetonide is a more potent derivative of triamcinolone and is approximately 8 times more potent than prednisone. Although the precise mechanism of corticosteroid anti-allergic action is unknown, corticosteroids are very effective in the treatment of allergic diseases in man. Also, local injections are thought to have an anti-inflammatory effect. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| D01AC20 | Combinations | D Dermatologicals → D01 Antifungals for dermatological use → D01A Antifungals for topical use → D01AC Imidazole and triazole derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 195669, 441279 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 66108628 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100052815, 100324461, 100384486 |
| Country: ZA | Health Products Regulatory Authority | Identifier(s): Q/13.4.1/0220 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
